Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 11/2011

01-11-2011 | Pediatric Original

Tidal volume delivery during surfactant administration in the delivery room

Authors: Georg M. Schmölzer, C. Omar F. Kamlin, Jennifer A. Dawson, Colin J. Morley, Peter G. Davis

Published in: Intensive Care Medicine | Issue 11/2011

Login to get access

Abstract

Purpose

Reduced mortality for infants born at less than 30 weeks’ gestation after prophylactic surfactant administration has led many to advocate routine intubation and administration of surfactant in all infants at risk of respiratory distress syndrome. However, surfactant administration is associated with adverse events including bradycardia, changes in cerebral blood flow and endotracheal tube obstruction. The aim of this study was to analyse respiratory function immediately before and after surfactant administration in the delivery room.

Methods

We reviewed video recordings of the initial resuscitation in the delivery room of infants born at less than 32 weeks’ gestation between February 2007 and March 2010. Positive pressure ventilation was delivered with either a Neopuff T-piece or self-inflating bag. Respiratory parameters were recorded with a respiratory function monitor (RFM). Each RFM recording was analysed for 30 s before and 2 min after surfactant administration.

Results

Of 230 infants recorded during the study period 16 infants received surfactant in the delivery room. Their mean (standard deviation, SD) gestation and birth weight were 25 (1) weeks and 757 (249) g, respectively. Complete airway obstruction was seen in 4/16 (25%) infants. The median (interquartile range, IQR) duration of this obstruction was 16 (8–27) s. The median (IQR) expired tidal volume before surfactant delivery was 8.0 (5.2–11.2) mL/kg compared to 4.6 (4.1–7.3) mL/kg (p = 0.03) after surfactant administration.

Conclusion

Substantial tidal volume changes occur before, during and after surfactant administration in the delivery room. Complete airway obstruction is common. Monitoring respiratory function during this procedure may help to assess the delivered tidal volume and airway pressures after surfactant treatment.
Literature
1.
Te Pas AB, Davis PG, Hooper SB, Morley CJ (2008) From liquid to air: breathing after birth. J Pediatr 152:607–611PubMedCrossRef
2.
Schmölzer GM, Kamlin OC, O’Donnell CP, Dawson JA, Morley CJ, Davis PG (2010) Assessment of tidal volume and gas leak during mask ventilation of preterm infants in the delivery room. Arch Dis Child Fetal Neonatal Ed 95:F393–F397PubMedCrossRef
3.
Poulton DA, Schmölzer GM, Morley CJ, Davis PG (2011) Assessment of chest rise during mask ventilation of preterm infants in the delivery room. Resuscitation 82:175–179PubMedCrossRef
4.
Johnston ED, Stenson BJ (2010) Am I getting chest wall movement? Arch Dis Child Fetal Neonatal Ed 95:F391–F392PubMedCrossRef
5.
Wada K, Jobe AH, Ikegami M (1997) Tidal volume effects on surfactant treatment responses with the initiation of ventilation in preterm lambs. J Appl Physiol 83:1054–1061PubMed
6.
Bjorklund LJ, Ingimarsson J, Curstedt T, John J, Robertson B, Werner O et al (1997) Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res 42:348–355PubMedCrossRef
7.
Soll RF, Morley CJ (2001) Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev (2):CD000510. doi:10.​1002/​14651858.​CD000510
8.
9.
10.
Soll RF, Özek E (1997) Prophylactic animal derived surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev (4):CD000511. doi:10.​1002/​14651858.​CD000511
11.
Soll RF, Blanco F (2000) Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev (2):CD000144. doi:10.​1002/​14651858.​CD000144
12.
Kresch MJ, Clive JM (1998) Meta-analyses of surfactant replacement therapy of infants with birth weights less than 2000 grams. J Perinatol 18:276–283PubMed
13.
Finer N (2006) To intubate or not—that is the question: continuous positive airway pressure versus surfactant and extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 91:F392–F394PubMedCrossRef
14.
Poets CF, Sens B (1996) Changes in intubation rates and outcome of very low birth weight infants: a population-based study. Pediatrics 98:24–27PubMed
15.
Aly H, Massaro AN, Patel K, El-Mohandes AA (2005) Is it safer to intubate premature infants in the delivery room? Pediatrics 115:1660–1665PubMedCrossRef
16.
Morley CJ (1997) Systematic review of prophylactic vs rescue surfactant. Arch Dis Child Fetal Neonatal Ed 77:F70–F74PubMedCrossRef
17.
Verder H (2007) Nasal CPAP has become an indispensable part of the primary treatment of newborns with respiratory distress syndrome. Acta Paediatr 96:482–484PubMedCrossRef
18.
Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrom K et al (1994) Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med 331:1051–1055PubMedCrossRef
19.
Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB (2008) Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 358:700–708PubMedCrossRef
20.
Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, Laptook AR et al (2010) Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 362:1970–1979PubMedCrossRef
21.
Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M et al (2000) Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 105:1194–1201PubMedCrossRef
22.
Ammari A, Suri M, Milisavljevic V, Sahni R, Bateman D, Sanocka U et al (2005) Variables associated with the early failure of nasal CPAP in very low birth weight infants. J Pediatr 147:341–347PubMedCrossRef
23.
Wheeler KI, Davis PG, Kamlin CO, Morley CJ (2009) Assist control volume guarantee ventilation during surfactant administration. Arch Dis Child Fetal Neonatal Ed 94:F336–F338PubMedCrossRef
24.
Hudak ML, Martin DJ, Egan EA, Matteson EJ, Cummings NJ, Jung AL et al (1997) A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome. Pediatrics 100:39–50PubMedCrossRef
25.
Hentschel R, Brune T, Franke N, Harms E, Jorch G (2002) Sequential changes in compliance and resistance after bolus administration or slow infusion of surfactant in preterm infants. Intensive Care Med 28:622–628PubMedCrossRef
26.
27.
Sehgal A, Mak W, Dunn M, Kelly E, Whyte H, McCrindle B et al (2010) Haemodynamic changes after delivery room surfactant administration to very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 95:F345–F351PubMedCrossRef
28.
Lefort S, Diniz EM, Vaz FA (2003) Clinical course of premature infants intubated in the delivery room, submitted or not to porcine-derived lung surfactant therapy within the first hour of life. J Matern Fetal Neonatal Med 14:187–196PubMedCrossRef
29.
Skov L, Hellstrom-Westas L, Jacobsen T, Greisen G, Svenningsen NW (1992) Acute changes in cerebral oxygenation and cerebral blood volume in preterm infants during surfactant treatment. Neuropediatrics 23:126–130PubMedCrossRef
30.
Skov L, Bell A, Greisen G (1992) Surfactant administration and the cerebral circulation. Biol Neonate 61(Suppl 1):31–36PubMed
31.
Dawson JA, Schmolzer GM, Kamlin CO, Te Pas AB, O’Donnell CP, Donath SM et al (2011) Oxygenation with T-piece versus self-inflating bag for ventilation of extremely preterm infants at birth: a randomized controlled trial. J Pediatr 158:912–918 e2PubMedCrossRef
32.
Dawson JA, Davis PG, O’Donnell CP, Kamlin CO, Morley CJ (2007) Pulse oximetry for monitoring infants in the delivery room: a review. Arch Dis Child Fetal Neonatal Ed 92(1):F4–F7PubMedCrossRef
33.
Finer N, Leone T (2009) Oxygen saturation monitoring for the preterm infant: the evidence basis for current practice. Pediatr Res 65:375–380PubMedCrossRef
34.
Finer NN, Carlo WA, Duara S, Fanaroff AA, Donovan EF, Wright LL et al (2004) Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial. Pediatrics 114:651–657PubMedCrossRef
35.
Gagliardi L, Bellu R, Lista G, Zanini R (2011) Do differences in delivery room intubation explain different rates of bronchopulmonary dysplasia between hospitals? Arch Dis Child Fetal Neonatal Ed 96:F30–F35PubMedCrossRef
36.
Schmölzer GM, Te Pas AB, Davis PG, Morley CJ (2008) Reducing lung injury during neonatal resuscitation of preterm infants. J Pediatr 153:741–745PubMedCrossRef
37.
Abdel-Latif ME, Osborn DA (2011) Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome. Cochrane Database Syst Rev 3:CD008311PubMed
38.
Abdel-Latif ME, Osborn DA (2011) Intratracheal Clara cell secretory protein (CCSP) administration in preterm infants with or at risk of respiratory distress syndrome. Cochrane Database Syst Rev 5:CD008308PubMed
39.
Trevisanuto D, Grazzina N, Ferrarese P, Micaglio M, Verghese C, Zanardo V (2005) Laryngeal mask airway used as a delivery conduit for the administration of surfactant to preterm infants with respiratory distress syndrome. Biol Neonate 87:217–220PubMedCrossRef
40.
Vento M, Cheung PY, Aguar M (2008) The first golden minutes of the extremely-low-gestational-age neonate: a gentle approach. Neonatology 95:286–298PubMedCrossRef
41.
Hillman NH, Moss TJ, Kallapur SG, Bachurski C, Pillow JJ, Polglase GR et al (2007) Brief, large tidal volume ventilation initiates lung injury and a systemic response in fetal sheep. Am J Respir Crit Care Med 176:575–581PubMedCrossRef
42.
Polglase GR, Hillman NH, Pillow JJ, Cheah FC, Nitsos I, Moss TJ et al (2008) Positive end-expiratory pressure and tidal volume during initial ventilation of preterm lambs. Pediatr Res 64:517–522PubMedCrossRef
43.
44.
Kattwinkel J, Perlman JM, Aziz K, Colby C, Fairchild K, Gallagher J et al (2010) Special report–neonatal resuscitation: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Pediatrics 126:e1400–e1413PubMedCrossRef
Metadata
Title
Tidal volume delivery during surfactant administration in the delivery room
Authors
Georg M. Schmölzer
C. Omar F. Kamlin
Jennifer A. Dawson
Colin J. Morley
Peter G. Davis
Publication date
01-11-2011
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 11/2011
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-011-2366-2

Other articles of this Issue 11/2011

Intensive Care Medicine 11/2011 Go to the issue

Original

The obesity paradox in surgical intensive care unit patients

Correspondence

A large postoperative left ventricular hemorrhagic contusion and management by prolonged mechanical circulatory support: a case report

Original

Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study

Original

Delivery of helium–oxygen mixture during spontaneous breathing: evaluation of three high-concentration face masks

Experimental

High dose methylprednisolone counteracts the negative effects of rocuronium on diaphragm function

Correspondence

Cystatin C is not a reliable marker of residual glomerular filtration rate during continuous renal replacement therapy